Gilead Sciences, Inc. (GILD) Revenue by Segment
Gilead Sciences revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), Gilead Sciences's largest product or service was Product, with $7.63 billion or 98% of revenue, up 8.1% from a year earlier. Next: Royalty, Contract, And Other (2%).
By region, United States brought in 72%, Europe brought in 17% and Rest of World brought in 11% of revenue in Q2 fiscal 2026.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.
Gilead Sciences, Inc.
Revenue breakdown
Fiscal quarters, from company filings
Gilead Sciences revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Product | $7.6B | $6.9B | $7.3B | $7.1B | 98% |
| Royalty, Contract, And Other | $176.0M | $14.0M | $424.0M | $27.0M | 2% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Gilead Sciences revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $5.6B | $4.9B | $5.3B | $5.1B | 72% |
| Europe | $1.3B | $1.1B | $1.6B | $1.2B | 17% |
| Rest of World | $876.0M | $889.0M | $933.0M | $842.0M | 11% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
Which product or service makes the most money for Gilead Sciences?
Product: $7.63 billion, or 98% of revenue, in Q2 fiscal 2026.
What are Gilead Sciences's main products and services?
By revenue in Q2 fiscal 2026: Product (98%) and Royalty, Contract, And Other (2%).
Where does Gilead Sciences make its money?
By region in Q2 fiscal 2026: United States (72%), Europe (17%) and Rest of World (11%).
